Cell ReportsGenomicsPeer-reviewed journal article
Epigenome dysregulation resulting from NSD1 mutation in head and neck squamous cell carcinoma
Nargess FarhangdoostiD, Cynthia HorthiD, Bo HuiD, Eric BarekeiD, Xiao CheniD, Yinglu LiiD, Mariel CoradiniD, Benjamin A. GarciaiD, Chao LüiD, Jacek MajewskiiD
Abstract
Epigenetic dysregulation has emerged as an important mechanism of oncogenesis. To develop targeted treatments, it is important to understand the epigenetic and transcriptomic consequences of mutations in epigenetic modifier genes. Recently, mutations in the histone methyltransferase gene NSD1 have been identified in a subset of head and neck squamous cell carcinomas (HNSCCs) - one of the most common and deadly cancers. Here, we use whole (epi)genome approaches and genome editing to dissect the downstream effects of loss of NSD1 in HNSCC. We demonstrate that NSD1 mutations are directly responsible for loss of intergenic H3K36me2 domains, followed by loss of DNA methylation, and gain of H3K27me3 in the affected genomic regions. We further show that those regions are enriched in cis-regulatory elements and that subsequent loss of H3K27ac correlates with reduced expression of their target genes. Our analysis identifies genes and pathways affected by the loss of NSD1 and paves the way to further understanding the interplay among chromatin modifications in cancer.
- organism: human
- assay: ChIP-seq
- assay: DNA methylation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
- Citations
- 67
- FWCI
- 4.08
- Field percentile
- top 4%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
K. Brennan, J. H. Shin, … O. Gevaert·bioRxiv·Oct 20, 2017
- Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
- Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific genetic changes associated with immortalisation and malignancy.
R. Veeramachaneni, T. Walker, … N. Thakker·bioRxiv·Jul 9, 2018
- Deciphering the function of intrinsic and genomics-driven epigenetic heterogeneity in head and neck cancer progression with single-nucleus CUT&RUN
H. Womerley, D. Muliaditan, … L. F. Cheow·bioRxiv·Feb 14, 2024
- The T1150A cancer mutant of the protein lysine dimethyltransferase NSD2 can introduce H3K36 trimethylation
Mina S. Khella, Philipp Schnee, … Albert Jeltsch·Journal of Biological ChemistryPeer-reviewed·May 5, 2023
- NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma.
I. Topchu, I. Bychkov, … Y. Boumber·bioRxiv·Sep 19, 2023